Scarica l'app Stockscreener
6.31
2.02%
-0.13
Dopo l'orario di chiusura:
3.43
-2.88
-45.64%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.44
Aprire:
$6.4
Volume 24 ore:
809.77K
Relative Volume:
0.93
Capitalizzazione di mercato:
$934.52M
Reddito:
$342.81M
Utile/perdita netta:
$97.67M
Rapporto P/E:
10.27
EPS:
0.6145
Flusso di cassa netto:
$50.46M
1 W Prestazione:
-6.79%
1M Prestazione:
-5.54%
6M Prestazione:
-9.86%
1 anno Prestazione:
-28.70%
Intervallo 1D:
$6.30
$6.4397
Intervallo di 1 settimana:
$6.25
$6.79
Portata 52W:
$5.79
$9.362
Mimedx Group Inc Stock (MDXG) Company Profile
Nome
Mimedx Group Inc
Settore
Industria
Telefono
(770) 651-9100
Indirizzo
1775 W OAK COMMONS COURT, NE, MARIETTA
Confronta MDXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.64 | 4.50B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.50 | 447.72M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.61 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.30 | 322.97M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.49 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Iniziato | Lake Street | Buy |
| 2023-10-27 | Iniziato | Craig Hallum | Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-07-26 | Iniziato | Northland Capital | Outperform |
| 2021-03-19 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Mimedx Group Inc Borsa (MDXG) Ultime notizie
Aug Wrap: What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Highlights & Real-Time Sentiment Analysis - ulpravda.ru
Can MiMedx Group Inc. stock continue upward trendDividend Hike & Daily Growth Stock Investment Tips - ulpravda.ru
MiMedx Group Inc Is Quietly Going Off: Is MDXG the Sleeper Stock You’re Sleeping On? - AD HOC NEWS
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
Institution Moves: Can MiMedx Group Inc stock continue upward trendCPI Data & Daily Market Momentum Tracking - moha.gov.vn
Harbor Capital Advisors Inc. Cuts Holdings in MiMedx Group, Inc $MDXG - MarketBeat
Northland Securities Remains a Buy on MiMedx Group (MDXG) - The Globe and Mail
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - Sahm
MiMedx Group Signs Exclusive Agreement to Distribute Regen Lab USA's RegenKit-Wound Gel in US - marketscreener.com
MiMedx (MDXG) Secures Exclusive Deal for U.S. Distribution of Re - GuruFocus
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel - Investing.com
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel By Investing.com - Investing.com South Africa
MiMedx Group, Inc. Partners with Regen Lab USA LLC to Distribute RegenKit®-Wound Gel in the U.S. - Quiver Quantitative
Mimedx Enters into Exclusive U.S. Distribution Agreement for Regenkit®?-Wound Gel - marketscreener.com
Value Recap: Why MiMedx Group Inc stock remains undervaluedWeekly Risk Report & Weekly Top Performers Watchlists - moha.gov.vn
Will MiMedx Group Inc. stock gain from lower inflationJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest - Yahoo Finance
MIMEDX reports immunomodulatory effects of placental allografts By Investing.com - Investing.com Australia
Will MiMedx Group Inc. stock deliver consistent dividendsJuly 2025 Retail & Expert Approved Momentum Ideas - Улправда
What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Price Swings & Short-Term Trading Opportunity Alerts - DonanımHaber
MIMEDX reports immunomodulatory effects of placental allografts - Investing.com
MiMedx (MDXG) Highlights New Study Showcasing Immunomodulatory B - GuruFocus
MiMedx Group, Inc. Announces New Research Supporting Immunomodulatory Effects of Amniotic Membrane Allografts - Quiver Quantitative
MIMEDX Announces Publication in the Journal of Inflammation - GlobeNewswire
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro - Sahm
Lab study finds placental tissue grafts may help reset wound healing - Stock Titan
Fundamentals Check: Can MiMedx Group Inc. stock maintain operating margins2025 Analyst Calls & Fast Entry Momentum Trade Alerts - ulpravda.ru
Can MiMedx Group Inc. stock maintain operating marginsSell Signal & Growth Oriented Trading Recommendations - Улправда
Mizuho Maintains MiMedx Group (MDXG) Outperform Recommendation - Nasdaq
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $10.00 at Mizuho - MarketBeat
MiMedx price target lowered to $10 from $12 at Mizuho - TipRanks
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), MiMedx Group (MDXG) - The Globe and Mail
Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
MiMedx Group Builds Momentum In Wound Care And Surgical Applications - RTTNews
Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why MiMedx Group Inc. stock remains undervaluedWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
How currency fluctuations impact MiMedx Group Inc. stockJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Geode Capital Management LLC Decreases Stock Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx announces publication of interim results from CAMPAIGN trial - MSN
MiMedx Group Inc. Reports Record Q3 Revenue - MSN
MiMedx Group (MDXG) Is Down 8.4% After Strong CAMPAIGN Trial Results for EPIEFFECT Product – What's Changed - simplywall.st
MiMedx Group (MDXG) Is Down 8.4% After EPIEFFECT’s Strong Interim Trial Data Outshines Standard Care - Yahoo Finance
Is MiMedx Group Inc. stock attractive for long term wealth building - newser.com
Is MiMedx Group Inc. stock a good choice for value investors2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com
Will MiMedx Group Inc. stock maintain dividend yieldFed Meeting & Smart Money Movement Tracker - newser.com
Can MiMedx Group Inc. stock sustain market leadershipJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Is MiMedx Group Inc. showing signs of accumulationVolume Spike & Pattern Based Trade Signal System - newser.com
Will MiMedx Group Inc. stock go up soon2025 Historical Comparison & Risk Managed Trade Strategies - newser.com
Mimedx Group Inc Azioni (MDXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):